Development of a Decafluorobiphenyl Cyclized Peptide Targeting the NEMO–IKKα/β Interaction that Enhances Cell Penetration and Attenuates Lipopolysaccharide-Induced Acute Lung Injury
Bioconjugate Chemistry · 2024
DOI: 10.1021/acs.bioconjchem.4c00122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2024. Verfasst von Shu Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Molecular Biology, School of Life Sciences, Lanzhou University, Lanzhou 730000, China. Hauptthemen laut MEDLINE: I-kappa B Kinase, Acute Lung Injury, Lipopolysaccharides, Peptides, Cyclic. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Natural Science Foundation of Gansu Province, Fundamental Research Creative Groups of Gansu Province.
Abstract (Originalsprache)
Aberrant canonical NF-κB signaling has been implicated in diseases, such as autoimmune disorders and cancer. Direct disruption of the interaction of NEMO and IKKα/β has been developed as a novel way to inhibit the overactivation of NF-κB. Peptides are a potential solution for disrupting protein-protein interactions (PPIs); however, they typically suffer from poor stability in vivo and limited tissue penetration permeability, hampering their widespread use as new chemical biology tools and potential therapeutics. In this work, decafluorobiphenyl-cysteine SNAr chemistry, molecular modeling, and biological validation allowed the development of peptide PPI inhibitors. The resulting cyclic peptide specifically inhibited canonical NF-κB signaling in vitro and in vivo, and presented positive metabolic stability, anti-inflammatory effects, and low cytotoxicity. Importantly, our results also revealed that cyclic peptides had huge potential in acute lung injury (ALI) treatment, and confirmed the role of the decafluorobiphenyl-based cyclization strategy in enhancing the biological activity of peptide NEMO-IKKα/β inhibitors. Moreover, it provided a promising method for the development of peptide-PPI inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry and Molecular Biology, School of Life Sciences, Lanzhou University, Lanzhou 730000, China.
- Key Laboratory of Xinjiang Endemic Phytomedicine Resources Ministry of Education, Shihezi University College of Pharmacy, Shihezi 832003, Xinjiang, China.
- State Key Laboratory of Applied Organic Chemistry and Department of Chemistry, Lanzhou University, Lanzhou 730000, China.
ORCID-Profile: Xiaojun Yao, Min Chang
Förderung
- Natural Science Foundation of Gansu Province
- Fundamental Research Creative Groups of Gansu Province
Zitieren
APA
Li, S., Song, S., Liu, X., Zhang, X., Liang, X., Chang, X., Zhou, D., Han, J., Nie, Y., Guo, C., Yao, X., Chang, M., & Peng, Y. (2024). Development of a Decafluorobiphenyl Cyclized Peptide Targeting the NEMO–IKKα/β Interaction that Enhances Cell Penetration and Attenuates Lipopolysaccharide-Induced Acute Lung Injury. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.4c00122
Vancouver
Li S, Song S, Liu X, Zhang X, Liang X, Chang X, et al. Development of a Decafluorobiphenyl Cyclized Peptide Targeting the NEMO–IKKα/β Interaction that Enhances Cell Penetration and Attenuates Lipopolysaccharide-Induced Acute Lung Injury. Bioconjugate Chemistry. 2024. doi:10.1021/acs.bioconjchem.4c00122
BibTeX
@article{Li2024,
author = {Li, Shu and Song, Shibo and Liu, Xiaojing and Zhang, Xingjiao and Liang, Xueya and Chang, Xin and Zhou, Daijun and Han, Jianting and Nie, Yaoyan and Guo, Chen and Yao, Xiaojun and Chang, Min and Peng, Yali},
title = {Development of a Decafluorobiphenyl Cyclized Peptide Targeting the NEMO–IKKα/β Interaction that Enhances Cell Penetration and Attenuates Lipopolysaccharide-Induced Acute Lung Injury},
journal = {Bioconjugate Chemistry},
year = {2024},
doi = {10.1021/acs.bioconjchem.4c00122}
}
EUVIMED